Introduced
S. 1302
Introduced in Senate · April 16, 2025April 3, 2025
Ms. Hassan (for herself, Mr. Paul, Mr. Hickenlooper, and Mr. Lee) introduced the following bill; which was read twice and referred to the Committee on Health, Education, Labor, and Pensions
A BILL
To provide for increased transparency in generic drug applications.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. Short title.
This Act may be cited as the “Increasing Transparency in Generic Drug Applications Act”.